Nanobiotix is trading at $43.99, up 5.97%, primarily linked to biotech-sector strength, with the XBI ETF up 2.06%.

  • The move extends Nanobiotix’s rebound from the August 24 close.
  • No major Nanobiotix announcement or analyst action was identified for August 26, 2026.
  • Its investor-relations page lists July 30, 2026, as its latest update.